The page below is a sample from the LabCE course Multi-drug Resistant Organisms: MRSA, VRE, and Clostridium difficile. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Multi-drug Resistant Organisms: MRSA, VRE, and Clostridium difficile (online CE course) »
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 94 CE courses, most popular
$95 Add to cart
Pick Your Courses
Up to 8 CE hours
$50 Add to cart
Individual course$20 Add to cart

Future Perspectives, continued

Important epidemiological and microbiological differences exist between CA- and HA-MRSA strains. Therefore, strategies to prevent and treat these infections should also differ. To prevent clinical complications from CA-MRSA, it is recommended that culturing and susceptibility testing of S. aureus clinical isolates become routine practice along with more careful selection and use of antimicrobials when treatment is indicated. MRSA isolates are NOT susceptible to beta-lactam antibiotics, however CA-MRSA infections are susceptible to some currently available non- beta-lactam antibiotics such as clindamycin and trimethoprim/sulfamethoxazole.